Maria Vittoria Cossu
Overview
Explore the profile of Maria Vittoria Cossu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
476
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ciccullo A, Baldin G, Cervo A, Moschese D, Lagi F, Cossu M, et al.
J Antimicrob Chemother
. 2024 Oct;
80(1):175-177.
PMID: 39478330
Objectives: We compared the effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC/FTC/TAF) and dolutegravir plus lamivudine (DTG + 3TC) in our cohort of treatment-naive people with HIV (PWH). Methods: In...
2.
Rizzo A, Moschese D, Salari F, Giacomelli A, Cavallo A, Cossu M, et al.
J Med Virol
. 2024 Aug;
96(8):e29852.
PMID: 39166456
The association between human papillomavirus (HPV) and other sexually transmitted infections (STIs) in anal lesions still remains unclear. Aim of the study was to evaluate the prevalence of simultaneous infection...
3.
Iannone V, Ciccullo A, Moschese D, Giacomelli A, Fabbiani M, Lagi F, et al.
J Acquir Immune Defic Syndr
. 2024 May;
96(2):e10-e11.
PMID: 38771757
No abstract available.
4.
Giacomelli A, Cattaneo D, Pozza G, Moschese D, Cossu M, Dalu D, et al.
J Antimicrob Chemother
. 2024 Apr;
79(7):1708-1709.
PMID: 38661237
No abstract available.
5.
Cossu M, DAvolio A, Gervasoni C, Giacomelli A, Cattaneo D, Moschese D
Antimicrob Agents Chemother
. 2024 Mar;
68(5):e0017524.
PMID: 38534104
No abstract available.
6.
Cossu M, Cattaneo D, Moschese D, Giacomelli A, Soloperto S, DAvolio A, et al.
J Antimicrob Chemother
. 2024 Mar;
79(5):1126-1132.
PMID: 38530862
Objective: Large inter-individual variability in the pharmacokinetics of rilpivirine and cabotegravir has been reported in the first weeks after starting long-acting injectable (LAI) therapy. Here, we assessed the distribution of...
7.
Borgonovo F, Lovaglio P, Mariani C, Berta P, Cossu M, Rizzardini G, et al.
BMJ Open
. 2024 Feb;
14(2):e075185.
PMID: 38320835
Objective: To define macro symptoms of long COVID and to identify predictive factors, with the aim of preventing the development of the long COVID syndrome. Design: A single-centre longitudinal prospective...
8.
Rizzo A, Salari F, Eplite A, Giacomelli A, Moschese D, Dalu D, et al.
Infect Dis (Lond)
. 2024 Jan;
56(4):293-298.
PMID: 38217420
Background: Oral human papillomavirus (HPV) is common among healthy individuals but causes and implications of persistent infections are under evaluation in the pathogenesis of head and neck neoplasms. Methods: This...
9.
Rizzo A, Moschese D, Salari F, Giacomelli A, Morelli L, Cossu M, et al.
J Med Virol
. 2024 Jan;
96(1):e29370.
PMID: 38197518
Human papillomavirus (HPV) is the most common sexually transmitted infection, linked to several types of lesions. HPV, specifically HPV 16, accounts for most of anal cancer cases. In this study,...
10.
Giacomelli A, Cossu M, Moschese D, Gervasoni C
J Antimicrob Chemother
. 2023 Oct;
78(12):3009-3010.
PMID: 37823428
No abstract available.